Barriers to Participation in Cardiac Rehabilitation Among Patients with Coronary Heart Disease After Reperfusion Therapy: A Scoping Review

Firman Sugiharto,Aan Nuraeni,Yanny Trisyani,Azalia Melati Putri,Nuraulia Aghnia Armansyah
DOI: https://doi.org/10.2147/VHRM.S425505
2023-08-31
Vascular Health and Risk Management
Abstract:Firman Sugiharto, 1 Aan Nuraeni, 2 Yanny Trisyani, 2 Azalia Melati Putri, 1 Nuraulia Aghnia Armansyah 1 1 Faculty of Nursing, Universitas Padjadjaran, Sumedang, Jawa Barat, Indonesia; 2 Department of Critical Care and Emergency Nursing, Faculty of Nursing, Universitas Padjadjaran, Sumedang, Jawa Barat, Indonesia Correspondence: Firman Sugiharto, Faculty of Nursing, Universitas Padjadjaran, Jl. Raya Ir. Soekarno KM. 21, Hegarmanah, Jatinangor, Sumedang, West Java, 45363, Indonesia, Tel +6282218235600, Fax +6282287793411, Email Patients with coronary heart disease (CHD) experience many barriers to participate in cardiac rehabilitation (CR) programs. Several studies identify barriers that can affect participation in CR among patients with CHD after reperfusion therapy. However, there has yet to be a review specifically in this population. This review aims to identify the literature systematically that analyzes the barriers that affect the participation of CHD patients after reperfusion therapy in implementing the CR program. This study used the Preferred Reporting Item for PRISMA Extension for Scoping Reviews (PRISMA-ScR) with databases PubMed, ScienceDirect, EBSCO-hosted Academic Search Complete, Scopus, Taylor & Francis, and Sage Journals. The keywords used in English were "coronary artery disease OR myocardial infarction OR cardiovascular disease OR heart disease" AND "Barrier OR obstacle", AND "percutaneous coronary intervention OR PCI OR angioplasty OR coronary artery bypass graft surgery OR CABG" AND "cardiac rehabilitation OR rehabilitation OR recovery". The inclusion criteria in this review were full-text articles in English, articles with a descriptive, cross-sectional, and cohort design with a minimum of 100 participants that discussed barriers to participation in patients with CHD after undergoing reperfusion therapy, and the CR phases such as I, II, III, and IV have also been identified. Based on the initial search, there are 23 relevant studies out of 7400. The results of this study reported that most of the participants from the studies analyzed had a low level of participation in CR (≤ 50%). We classify the factors that affect the level of CR participation into five categories: individual factors, health history, environmental, logistical, and health system. The most reported barriers in each category were age, comorbidities, lack of support from friends, family and health workers, distance or travel time, and cost and economic status. Professional health workers, especially nurses, can identify various barriers that patients feel so that they can increase their participation in attending CR. Keywords: cardiac rehabilitation, coronary heart disease, patient participation, reperfusion Coronary heart disease (CHD) is still a significant health problem with high morbidity and mortality rates in various countries. 1 Globally, as many as 244.1 million people were living with ischemic heart disease (IHD) in 2020. 2 Based on data recorded in 2020, the death rate caused by this disease reached 112.37 per 100,000 with the highest IHD mortality rate occurring in North Africa and Middle East, Eastern Europe and Central Asia regions. 2 Unfortunately, according to World Health Organization (WHO), this mortality rate is expected to continue to increase to 24.2 million people in 2030. 3 Reperfusion therapy is one of the solutions to reduce the morbidity and mortality of patients with CHD. 2 This therapy aims to restore blocked blood flow through the coronary arteries with good standard and quality. 2 Over the past ten years, several evidence has supported using reperfusion therapy to reduce morbidity and mortality in CHD patients. 4 However, despite the many benefits of this therapy, patients undergoing reperfusion therapy often experience adverse cardiovascular events (MACE), which increase the length of hospitalization and lead to death. 5,6 Thus, ensuring adequate precautions are taken to reduce complications and improve the prognosis of CHD patients who have undergone reperfusion therapy is essential. 7–9 Cardiac rehabilitation (CR) is an interdisciplinary and comprehensive secondary prevention care model that effectively reduces mortality and MACE rates in patients with CHD after reperfusion therapy. 10,11 Previous reviews have proven that CR can significantly be reduced all-cause mortality by 13%-26%, cardiac death by 20%-36%, recurrent infarction by 25–47%, and some by other risk factors. 12 CR can also delay the development of atherosclerosis, even reverse plaque formation and prevent arterial blockage by a thrombus. 13 CR programs consist of physical training and education focused on risk factor manage -Abstract Truncated-
What problem does this paper attempt to address?